Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 2UNKNOWN 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 23Gastrointestinal 14Head & Neck 11Gynecologic 3Dermatologic 3Sarcoma 2Lymphoid 2Breast 2CNS 1

Conditions

Sarcoma 1Osteosarcoma 1Bone Neoplasms 1

Interventions

Radiotherapy 137Cyclophosphamide 132Temozolomide 116Doxorubicin 99Filgrastim 68Ifosfamide 64Gemcitabine 58Etoposide 55Bevacizumab 51Imatinib Mesylate 50fludarabine phosphate 49Irinotecan 46pembrolizumab 45Peripheral Blood Stem Cell Transplantation 45pazopanib 43Magnetic Resonance Spectroscopy 42Methotrexate 40Carboplatin 40Busulfan 40Vincristine 38Surgical Procedures, Operative 37Nivolumab 37Melphalan 37Cisplatin 36Radiation 34Blood Specimen Collection 33Mycophenolic Acid 31Cyclosporine 31Docetaxel 29Trabectedin 28

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × endostar protein × Sarcoma × Clear all
NCT06562673 2025-12-29

IACE-OS

Shanghai 6th People's Hospital

Phase 1/2 Completed
10 enrolled
Sarcoma

Bone Neoplasms, Osteosarcoma

NCT03121833 2019-12-26

Endostar Combined With Chemotherapy for Stage â…£ Soft Tissue Sarcoma

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Completed
52 enrolled
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡